Throat Pastilles and Cough Drops Market 2026, Advantages Over Other Dosage Forms to Boost Growth - Technavio
NEW YORK, Sept. 27, 2022 /PRNewswire/ -- The throat pastilles and cough drop market is expected to grow by USD 1.11 billion during 2021-2026, at a CAGR of 3.61% during the forecast period, according to Technavio. The advantages over other dosage forms, increasing incidences of respiratory tract infections, and expanding geriatric population base will offer immense growth opportunities.
However, side effects and challenges associated with excipients, the fragmented nature of the market and the increasing use of homemade remedies will challenge the growth of the market participants.
To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Request Free Sample Report.
Throat Pastilles and Cough Drops Market Segmentation
Type
Hard Tablet Lozenges
Soft Tablet Lozenges
Compressed Tablet Lozenges
Geography
North America
Europe
Asia
Rest Of World (ROW)
Throat Pastilles and Cough Drops Market Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our throat pastilles and cough drops market report covers the following areas:
Throat Pastilles and Cough Drops Market size
Throat Pastilles and Cough Drops Market trends
Throat Pastilles and Cough Drops Market industry analysis
This study identifies the emergence of innovative products as one of the prime reasons driving the throat pastilles and cough drops market growth during the next few years. Buy Sample Report.
Throat Pastilles and Cough Drops Market Vendor Analysis
We provide a detailed analysis of around 25 vendors operating in the Throat Pastilles and Cough Drops Market, including some of the vendors such as vendors Backed with competitive intelligence and benchmarking, our research reports on the Throat Pastilles and Cough Drops Market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Blackmores Ltd.
Dr. Willmar Schwabe India Pvt. Ltd.
Ernest Jackson & Co. Ltd
GlaxoSmithKline Plc
iNova Pharmaceuticals
Island Abbey Foods Ltd.
Johnson and Johnson
Pfizer Inc.
Prestige Consumer Healthcare Inc.
Reckitt Benckiser Group PLC
Ricola Ltd.
Sanofi SA
The Procter and Gamble Co.
Belmora LLC
Find additional highlights on the growth strategies adopted by vendors and their product offerings, Download Free Sample Report.
Throat Pastilles and Cough Drops Market Key Highlights
CAGR of the market during the forecast period
Detailed information on factors that will assist throat pastilles and cough drops market growth during the next five years
Estimation of the throat pastilles and cough drops market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the throat pastilles and cough drops market
Analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of throat pastilles and cough drops market vendors
Related Reports:
Stem Cell Umbilical Cord Blood (UCB) Market by End-user and Geography - Forecast and Analysis 2022-2026: The stem cell umbilical cord blood (UCB) market share is expected to increase by $ 1.47 bn from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 16.87%.
Lennox-Gastaut Syndrome Treatment Market by Type and Geography - Forecast and Analysis 2022-2026: The Lennox-Gastaut Syndrome (LGS) treatment market share is expected to increase by USD 684.75 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.42%.
Throat Pastilles And Cough Drops Market Scope
Report Coverage
Details
Page number
120
Base year
2021
Forecast period
2022-2026
Growth momentum & CAGR
Accelerate at a CAGR of 3.61%
Market growth 2022-2026
$ 1.11 billion
Market structure
Fragmented
YoY growth (%)
3.21
Regional analysis
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 34%
Key consumer countries
US, Canada, Mexico, Germany, UK, and Japan
Competitive landscape
Leading companies, competitive strategies, consumer engagement scope
Companies profiled
Blackmores Ltd., Dr. Willmar Schwabe India Pvt. Ltd., Ernest Jackson & Co. Ltd, GlaxoSmithKline Plc, iNova Pharmaceuticals, Island Abbey Foods Ltd., Johnson and Johnson, Pfizer Inc., Prestige Consumer Healthcare Inc., Reckitt Benckiser Group PLC, Ricola Ltd., Sanofi SA, The Procter and Gamble Co., Belmora LLC, DISCH AG, Bliss GVS Pharma Ltd., Boyd Pharmaceuticals, Cipla Health Ltd., Lozys Pharmaceuticals SL, Thornton and Ross Ltd., and STADA Arzneimittel AG
Market Dynamics
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Table Of Contents :
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary ? Chart on Market Overview
Exhibit 02: Executive Summary ? Data Table on Market Overview
Exhibit 03: Executive Summary ? Chart on Global Market Characteristics
Exhibit 04: Executive Summary ? Chart on Market by Geography
Exhibit 05: Executive Summary ? Chart on Market Segmentation by Type
Exhibit 06: Executive Summary ? Chart on Incremental Growth
Exhibit 07: Executive Summary ? Data Table on Incremental Growth
Exhibit 08: Executive Summary ? Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers ? Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers ? Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants ? Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes ? Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry ? Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Hard tablet lozenges - Market size and forecast 2021-2026
Exhibit 28: Chart on Hard tablet lozenges - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Hard tablet lozenges - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Hard tablet lozenges - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Hard tablet lozenges - Year-over-year growth 2021-2026 (%)
5.4 Soft tablet lozenges - Market size and forecast 2021-2026
Exhibit 32: Chart on Soft tablet lozenges - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Soft tablet lozenges - Market size and forecast 2021-2026 ($ million)
Exhibit 132: Validation techniques employed for market sizing
Exhibit 133: Information sources
11.5 List of abbreviations
Exhibit 134: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against QuidelOrtho Corporation ("QuidelOrtho" or the "Company") and reminds investors of the June 11, 2024 deadline to seek the role of lead plaintiff...
The growing need for identity-centric security solutions brought on by an increase in cyberattacks and regulatory compliance requirements will define the Identity Threat Detection and Response (ITDR) Market in the future. The growth of ITDR solutions...
Red Pine Exploration Inc. ("Red Pine" or the "Company"), further to its press releases of May 1, 2024, and May 6, 2024 (the "Prior Press Releases"), provides a further update on the Company's progress on its investigations into the reporting...
Hyperfine, Inc. , the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system?the Swoop® system?today announced it has entered into agreements with...
Applied DNA Sciences, Inc. (Applied DNA), a leader in PCR-based DNA technologies, today announced that on May 9, 2024, it received a notification letter (the "Notification Letter") from the Listing Qualifications Department of the Nasdaq...